Docebo Q2 FY26 net income drops 26.6% to US$2.26 million; revenue rises 13% to US$68.65 million
DCBO•Outlook raised on enterprise traction
CEO Alessio Artuffo said enterprise traction in AI-driven workforce transformation supports raising the full-year outlook.
FY2026 revenue is now seen at USD 274.5 million-USD 276.5 million; Q3 revenue is guided to USD 69.5 million-USD 69.7 million.
Q2 results show revenue growth and lower net income
Docebo posted Q2 net income of USD 2.26 million, down 26.6%, as revenue climbed 13% to USD 68.65 million.
Adjusted EBITDA rose 21.8% to USD 11.23 million; gross margin slipped 1.5 percentage points to 79.4%.
Annual recurring revenue increased 9.5% to USD 255.1 million; free cash flow fell 73.1% to USD 3.07 million.
Related News
Under Armour FY27 Q1 net income swings to USD 545,000; revenue falls 3% to USD 1.1 billion
UAA•
Purple Biotech Q2 FY26 net income swings to USD 400,000; operating loss widens to USD 1.3 million
PPBT•
